Cover Image

Hepatitis C drug affordability

Saved in:

Bibliographic Details
Main Author:	Mohga Kamal-Yanni (Author)
Format:	Book
Published:	Elsevier, 2015-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short-term budget affordability of hepatitis C treatments for state Medicaid programs
by: Jacquelyn W. Chou, et al.
Published: (2019)

New drugs: who can afford them?
by: Jorge Antonio Zepeda Bermudez, et al.

Alcohol, hepatitis C screening and hepatic fibrosis in drug users
by: Di Nino F, et al.
Published: (2019)

Affordability of oncology drugs: accuracy of budget impact estimations
by: Joost W. Geenen, et al.
Published: (2020)

The impact of level of documentation on the accessibility and affordability of new drugs in Norway
by: Gro Live Fagereng, et al.
Published: (2024)

The strategies of drug supply for patients with chronic hepatitis C
by: E. V. Kornilova, et al.
Published: (2017)

Facing the health worker crisis in developing countries: a call for global solidarity
by: Mohga Kamal Smith, et al.
Published: (2006)

Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
by: Sun-Young Kim, et al.
Published: (2007)

World Trade Organization still threatens supply of affordable AIDS drugs
by: Michael Hagmann

Hepatitis C and Injection Drug Use: Testing and Linkage to Care
by: Marie Sutton, et al.
Published: (2016)

P17 The impact of hepatitis C-related uncertainty on self-reported stress in people who inject drugs living with hepatitis C
by: S. Goutzamanis, et al.
Published: (2017)

Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands
by: Bongaerts Monique, et al.
Published: (2010)

Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
by: Roberto Focaccia, et al.
Published: (2015)

Disparity in market prices for hepatitis C virus direct-acting drugs
by: Isabelle Andrieux-Meyer, et al.
Published: (2015)

Hepatitis C reinfection in former and active injecting drug users in Belgium
by: Dana Busschots, et al.
Published: (2021)

Injection Drug use and Hepatitis C: Interventions in Behavioral Health Settings
by: Marie Sutton
Published: (2017)

Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user
by: Milano Danielle, et al.
Published: (2004)

Therapeutic challenges in hepatitis C-infected injection drug using patients
by: Cooper Curtis L, et al.
Published: (2006)

Alternatives to the ACA's Affordability Firewall
by: Nowak, Sarah A.
Published: (2015)

Availability and affordability of medicines for children
by: Irina Kazaryan, et al.
Published: (2015)

Transitioning to Affordable and Clean Energy
Published: (2022)

Transitioning to Affordable and Clean Energy
Published: (2022)

Agency and Affordances in Study Abroad
by: Andrew D. Tweed, et al.
Published: (2023)

Price, availability and affordability of medicines
by: Brenda S. Mhlanga, et al.
Published: (2014)

Global affordability of fluoride toothpaste
by: Holmgren Christopher J, et al.
Published: (2008)

Mandates and the Affordability of Health Care
by: Sherry Glied
Published: (2009)

Integrating technologies into “authentic” assessment design: an affordances approach
by: Richard Osborne, et al.
Published: (2013)

Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
by: MI Naga, et al.
Published: (2019)

Investigating the availability, affordability, and market dynamics of innovative oncology drugs in Morocco: an original report
by: Nada Benhima, et al.
Published: (2024)

Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
by: Colene Bentley, et al.
Published: (2019)

Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
by: Seung Mi Lee, et al.
Published: (2021)

Study on the accessibility and affordability of 50 drugs in Wuhan based on the WHO/HAI standardization method
by: Zuojun Dong, et al.
Published: (2023)

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
by: Rafael Franco, et al.
Published: (2023)

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?
by: Akram Ahmad, et al.
Published: (2015)

The evolving Lebanese drug crisis: Trends in drug availability and affordability for common outpatient diseases from 2019 to 2023.
by: Rachel Jaber Chehayeb, et al.
Published: (2023)

The evolving Lebanese drug crisis: Trends in drug availability and affordability for common outpatient diseases from 2019 to 2023
by: Rachel Jaber Chehayeb, et al.
Published: (2023)

Hepatitis C in dermatology
by: Zonunsanga
Published: (2015)

Hepatitis B and C
Published: (2020)

Update on Hepatitis C
Published: (2017)

Cities and Affordable Housing Planning, Design and Policy Nexus
Published: (2022)